Utility of CMR in identification of post lung transplant cardiovascular complications
© Forouzandeh et al; licensee BioMed Central Ltd. 2012
Published: 1 February 2012
Graft dysfunction after lung transplantation is typically attributable to infection or rejection. In the absence of these entities, structural cardiovascular (CV) abnormalities need to be sought. At our center this evaluation typically includes a myriad of diagnostic tests: echocardiography, chest computed tomographic angiography, nuclear medicine lung perfusion imaging, and right heart catheterization (RHC). This study was designed to evaluate the utility of a novel comprehensive CMR protocol for identification of all post-operative structural CV complications in lung transplant recipients.
We enrolled 80 consecutive lung transplant recipients who were referred for CMR evaluation of CV abnormalities. There were 47 men and 33 women; mean age 56.7±13.6 years; 55 Caucasians, 9 Hispanic, 13 African American, and 3 Asian. Underlying restrictive disease was present in 39 subjects, obstructive disorders in 22, and other disorders in 19. Forty-three subjects had undergone double lung transplant, while 37 subjects had single lung transplant (23 left lung, and 14 right lung). The comprehensive CMR protocol included complete short and long axis cine imaging (SSFP) to evaluate cardiac size and function; ECG gated spin echo imaging to assess pericardial thickness; contrast enhanced MRA of the pulmonary arterial (PA) and venous (PV) systems to assess for anastomotic site stenosis; phase contrast velocity flow mapping to assess anastomotic site peak velocity and right and left PA flow fraction; and inversion recovery SSFP to evaluate for myocardial fibrosis.
PA Anastomotic Site Stenosis Moderate Stenosis (50-70%) Severe Stenosis (> 70%)
6 (8%) 2 (3%)
PV Anastomotic Site Stenosis Moderate Stenosis (50-70%) Severe Stenosis (> 70%)
1 (1%) 1 (1%)
Acquired pericardial cyst causing hemodynamic compromise
A comprehensive CMR protocol can be a useful single noninvasive test for the detection of structural cardiovascular (CV) abnormalities after lung transplantation.
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.